<a href="http://www.bloomberg.com/news/2014-05-12/samsung-invests-in-drugs-after-outselling-apple-s-iphone.html">By Kanoko Matsuyama and Jungah Lee -<br><br>South Korea’s biggest company is investing at least $2 billion in biopharmaceuticals, including the growing segment of biosimilars, which are cheaper versions of brand-name biotechnology drugs that have lost patent protection.<br><br>READ MORE ON BLOOMBERG</a>
Samsung getting into biopharmaceuticals - Wants to become a leading pharmaceutical company
